• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    BetterInvesting™ Magazine Update on Vertiv Holdings Co. (NYSE: VRT) and CVS Health Corp. (NYSE: CVS)

    9/30/25 10:20:00 AM ET
    $CVS
    $VRT
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Industrial Machinery/Components
    Technology
    Get the next $CVS alert in real time by email

    TROY, Mich., Sept. 30, 2025 /PRNewswire/ -- Vertiv Holdings Co.'s recent report has investors wondering if the company's stock is fairly valued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine consider Vertiv Holdings Co. (NYSE:VRT) as worthy of further study and has named the company its "Stock to Study" for the December 2025 issue for investors' informational and educational use.

    The fundamental data is eye-opening; investors can view Vertiv's sales, earnings, pre-tax profit, return on equity, and more all on one page, courtesy of the National Association of Investors Corp., at: https://ssg.betterinvesting.org/study/ssgplus/?studyid=17125916.

    A full report on Vertiv will appear in the December 2025 issue of BetterInvesting Magazine. 

    The same issue of BetterInvesting Magazine will also include a fundamental review of CVS Health Corp. (NYSE:CVS), which the independent Editorial Advisory and Securities Review Committee believes is worthy of further study from an undervalued perspective. 

    Committee members are Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Anne Nichols, CFA; and Dan Rutter, CFA.

    Doron P. Levin, an editor of the magazine, serves as the committee's chairperson.

    Securities mentioned are for study and presented for educational purposes only. They are not to be considered as endorsed or recommended for purchase by NAIC/BetterInvesting. Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision.

    About BetterInvesting:

    BetterInvesting™, a national 501(c)(3) nonprofit, investment education organization, has been empowering everyday Americans since 1951. Also known as the National Association of Investors™ (NAIC®), we have helped more than 5 million people from all walks of life learn how to improve their financial future. BetterInvesting provides unbiased, in-depth investing education and powerful online stock analysis tools to create successful lifelong investors. BetterInvesting staff, along with a dedicated community of volunteers across America, teach the organization's principles and time-tested methodology to individuals and investment clubs. For more information about BetterInvesting, please visit www.betterinvesting.org

    Follow us on LinkedIn, Instagram and Facebook.

    Contact: 877-275-6242

    Cision View original content:https://www.prnewswire.com/news-releases/betterinvesting-magazine-update-on-vertiv-holdings-co-nyse-vrt-and-cvs-health-corp-nyse-cvs-302571020.html

    SOURCE National Association of Investors/BetterInvesting

    Get the next $CVS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CVS
    $VRT

    CompanyDatePrice TargetRatingAnalyst
    Vertiv Holdings LLC
    $VRT
    1/2/2026$200.00Equal Weight → Overweight
    Barclays
    Vertiv Holdings LLC
    $VRT
    12/9/2025Outperform → Peer Perform
    Wolfe Research
    CVS Health Corporation
    $CVS
    10/14/2025$91.00Buy
    Goldman
    Vertiv Holdings LLC
    $VRT
    8/20/2025$135.00Neutral
    Rothschild & Co Redburn
    CVS Health Corporation
    $CVS
    8/18/2025$79.00Neutral → Buy
    UBS
    CVS Health Corporation
    $CVS
    8/14/2025$82.00Neutral → Outperform
    Robert W. Baird
    Vertiv Holdings LLC
    $VRT
    7/28/2025Outperform
    William Blair
    Vertiv Holdings LLC
    $VRT
    7/8/2025$165.00Hold → Buy
    Melius
    More analyst ratings

    $CVS
    $VRT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Vertiv upgraded by Barclays with a new price target

    Barclays upgraded Vertiv from Equal Weight to Overweight and set a new price target of $200.00

    1/2/26 7:19:46 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    Vertiv downgraded by Wolfe Research

    Wolfe Research downgraded Vertiv from Outperform to Peer Perform

    12/9/25 8:40:02 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    Goldman initiated coverage on CVS Health with a new price target

    Goldman initiated coverage of CVS Health with a rating of Buy and set a new price target of $91.00

    10/14/25 8:48:20 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $VRT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Vertiv Industrializes AI Deployment with Digitally Orchestrated Infrastructure, Collaborates with Hut 8 to Scale

    Vertiv™ OneCore factory-integrated, digitally validated infrastructure reduces on-site deployment complexity and accelerates schedule certainty amid tightening construction constraints COLUMBUS, Ohio, Feb. 26, 2026 /PRNewswire/ -- Vertiv (NYSE:VRT), a global leader in critical digital infrastructure, today announced a major evolution in high-density data center deployment, shifting from traditional static modeling to a higher fidelity Digital Twin platform. This technology-first approach accelerates the deployment of its Vertiv™ OneCore integrated modular solutions, enabling operators to scale AI factories with unprecedented velocity and precision.

    2/26/26 8:00:00 AM ET
    $HUT
    $VRT
    Finance: Consumer Services
    Finance
    Industrial Machinery/Components
    Technology

    CVS Pharmacy Partners with U.S. Soccer Federation and National Women's Soccer League to Promote Community Health and Wellness

    Building on its relationship with the Washington Spirit, CVS expands its commitment to soccer through a new multi-year sponsorship with the league and federation, which includes a national community field investment and partnering with the Kansas City Current and Seattle Reign FCWOONSOCKET, R.I., Feb. 19, 2026 /PRNewswire/ -- CVS Pharmacy® has furthered its commitment to improving community health by becoming an Official Health and Wellness Partner of the U.S. Soccer Federation (USSF) and the National Women's Soccer League (NWSL) and is backing that sponsorship with a multi-year investment to develop community multi‑use soccer fields in select markets across the country.

    2/19/26 9:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    CVS Health Announces $5 Million Scholarship Program to Support Future Pharmacists in Louisiana

    Investment aims to strengthen the pharmacy workforce and expand access to care across the stateBATON ROUGE, La., Feb. 18, 2026 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced the launch of a new $5 million scholarship program designed to support aspiring pharmacists in the state of Louisiana. The initiative will provide financial assistance to students pursuing their Doctor of Pharmacy (PharmD) degree at either Xavier University of Louisiana or the University of Louisiana at Monroe. This initiative is part of CVS Health's broader commitment to advancing health equity, exp

    2/18/26 8:00:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $VRT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CPO and General Counsel Khichi Samrat S. covered exercise/tax liability with 7,886 shares, decreasing direct ownership by 21% to 29,775 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    3/2/26 5:53:29 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    President and CEO Joyner J. David covered exercise/tax liability with 1,944 shares, decreasing direct ownership by 4% to 49,996 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    3/2/26 5:46:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Pres. Americas Sanghi Anand was granted 16,913 shares, increasing direct ownership by 87% to 36,361 units (SEC Form 4)

    4 - Vertiv Holdings Co (0001674101) (Issuer)

    2/17/26 8:08:25 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    $CVS
    $VRT
    SEC Filings

    View All

    SEC Form 144 filed by Vertiv Holdings LLC

    144 - Vertiv Holdings Co (0001674101) (Subject)

    2/27/26 4:38:30 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    SEC Form 144 filed by Vertiv Holdings LLC

    144 - Vertiv Holdings Co (0001674101) (Subject)

    2/27/26 4:38:30 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    SEC Form 144 filed by Vertiv Holdings LLC

    144 - Vertiv Holdings Co (0001674101) (Subject)

    2/27/26 4:38:30 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    $CVS
    $VRT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP and President, Aetna Nelson Steven H bought $1,289 worth of shares (24 units at $53.70) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    1/27/26 5:20:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    EVP and Chief People Officer Capozzi Heidi B bought $4,589 worth of shares (80 units at $57.36) (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    10/14/25 7:08:15 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Director Sansone Guy P bought $100,009 worth of shares (1,570 units at $63.70), increasing direct ownership by 15% to 12,007 units (SEC Form 4)

    4 - CVS HEALTH Corp (0000064803) (Issuer)

    6/9/25 8:22:46 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CVS
    $VRT
    Leadership Updates

    Live Leadership Updates

    View All

    CVS Health Helps Improve Access to More Affordable Fertility Treatments

    WOONSOCKET, R.I., Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE:CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Specialty Pharmacy and make it easier to pick up fertility medication at its 9,000 community pharmacy locations. CVS Specialty Pharmacy will be a core partner in the TrumpRx Fertility program. As the Trump Administration continues to establish more competitive prices for important medicines, the Administration has engaged with EMD Serono, manufacturer of Gonal-F an in-vitro fertilization (

    10/16/25 5:09:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Vertiv Announces Leadership Transition in EMEA Region

    Paul Ryan named as president, Europe, Middle East and Africa as of January 1, 2026 COLUMBUS, Ohio, Oct. 13, 2025 /PRNewswire/ -- Vertiv (NYSE:VRT), a global leader in critical digital infrastructure, today announced that Karsten Winther will retire from his position as president, Europe, Middle East and Africa (EMEA), effective December 31, 2025. Paul Ryan, currently chief procurement officer, has been appointed as his successor, starting January 1, 2026. "Karsten has made impactful contributions to Vertiv during his tenure, particularly in strengthening our EMEA region throug

    10/13/25 10:45:00 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    Vertiv Names Craig Chamberlin as Chief Financial Officer

    COLUMBUS, Ohio, Oct. 13, 2025 /PRNewswire/ -- Vertiv Holdings Co (NYSE:VRT), a global leader in critical digital infrastructure, today announced the appointment of Craig Chamberlin as Executive Vice President and Chief Financial Officer, effective November 10, 2025. Mr. Chamberlin succeeds David Fallon, who previously announced his intention to retire from Vertiv and serve as a consultant to the company through December 31, 2026. Mr. Chamberlin joins Vertiv from Wabtec Corporation, where he most recently served as Group Vice President and Chief Financial Officer of the company

    10/13/25 6:45:00 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    $CVS
    $VRT
    Financials

    Live finance-specific insights

    View All

    Vertiv Reports Strong Fourth Quarter with Organic Orders Growth of 252% and Diluted EPS Growth of 200% (Adjusted Diluted EPS +37%)

    Fourth Quarter 2025 Net sales of $2,880 million, 23% higher than fourth quarter 2024Operating profit up 27% and adjusted operating profit(1) up 33% from fourth quarter 2024. Adjusted operating margin of 23.2%, up 170 basis points compared to fourth quarter 2024Operating cash flow of $1,005 million and adjusted free cash flow(1) of $910 million, an increase of 136% and 151%, respectively, compared to prior year fourth quarter. Net leverage of ~0.5x at the end of fourth quarterFull Year 2025 Organic sales growth of 26% compared to prior year. Full year diluted EPS growth of 166% and adjusted diluted EPS growth of 47%. Full year operating cash flow of $2,114 million and adjusted free cash flow

    2/11/26 5:55:00 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS

    Fourth Quarter Highlights Total revenues increased to $105.7 billion, up 8.2% compared to prior yearGAAP diluted EPS of $2.30 and Adjusted EPS of $1.09Full-Year Highlights Total revenues increased to a record high $402.1 billion, up 7.8% compared to prior yearGAAP diluted EPS of $1.39 and Adjusted EPS of $6.75Generated cash flow from operations of $10.6 billionOperational Highlights CVS Pharmacy® successfully completed the transition to cost-based reimbursement across its Commercial, Third-Party Discount, Medicare and Medicaid businesses.Aetna® continues to improve the experience for health care professionals and their patients, approving more than 95% of all eligible prior authorizations wi

    2/10/26 6:30:00 AM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Vertiv Announces Date of Fourth Quarter and Full Year 2025 Earnings, and 2026 Investor Conference Date

    COLUMBUS, Ohio, Jan. 21, 2026 /PRNewswire/ -- Vertiv Holdings Co. (NYSE:VRT), a global leader in critical digital infrastructure, today announced it will report its fourth quarter and full year 2025 results before market open on Wednesday, February 11, 2026. The press release will contain a link to the presentation materials providing a fourth quarter and full year 2025 update, which will be available on Vertiv's website at investors.vertiv.com. Vertiv's management team will discuss the results during a conference call the same day, starting at 11 a.m. Eastern Time. This call will be webcast live and available for replay 30 days thereafter.

    1/21/26 8:00:00 AM ET
    $VRT
    Industrial Machinery/Components
    Technology

    $CVS
    $VRT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Vertiv Holdings LLC

    SC 13G - Vertiv Holdings Co (0001674101) (Subject)

    11/13/24 4:34:55 PM ET
    $VRT
    Industrial Machinery/Components
    Technology

    SEC Form SC 13G filed by CVS Health Corporation

    SC 13G - CVS HEALTH Corp (0000064803) (Subject)

    11/13/24 1:00:57 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: SEC Form SC 13G/A filed by Vertiv Holdings LLC

    SC 13G/A - Vertiv Holdings Co (0001674101) (Subject)

    11/12/24 5:49:48 PM ET
    $VRT
    Industrial Machinery/Components
    Technology